The involved signaling pathways include TGF-β1/Smad, Nrf2/ARE, PI3K/AKT, NF-κB, etc. It is worth noting that the same Chinese medicine often involves multiple signaling pathways to improve pulmonary fibrosis, suggesting that these Chinese medicines have multi-target effects. The gene discussed is AKT1; the disease is pulmonary fibrosis.